Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10051035
Abstract: Novel targeted therapies for metastatic colorectal cancer are needed to personalize treatments by guiding specific biomarkers selected on the genetic profile of patients. RAS and BRAF inhibitors have been developed for patients who become unresponsive… read more here.
Keywords: cancer heterogeneity; colorectal cancer; impact precision; heterogeneity impact ... See more keywords